(Q42108953)

16 October 2017

In vitro synergistic activities of aminoglycosides and new beta-lactams against multiresistant Pseudomonas aeruginosa (English)

1 reference

16 October 2017

multiple drug resistance

1 reference

based on heuristic

inferred from title

Pseudomonas aeruginosa

1 reference

Giamarellou H

1

1 reference

16 October 2017

Zissis NP

series ordinal

2

1 reference

16 October 2017

Tagari G

series ordinal

3

1 reference

16 October 2017

Bouzos J

series ordinal

4

1 reference

16 October 2017

language of work or name

English

0 references

publication date

1 April 1984

1 reference

Antimicrobial Agents and Chemotherapy

16 October 2017

1 reference

16 October 2017

25

1 reference

16 October 2017

534-536

1 reference

16 October 2017

4

1 reference

Antimicrobial activity of amikacin combinations against Enterobacteriaceae moderately susceptible to third-generation cephalosporins

16 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185575

Comparative in vitro synergistic activity of new beta-lactam antimicrobial agents and amikacin against Pseudomonas aeruginosa and Serratia marcescens

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185575

Comparative synergistic activity of cefoperazone, cefotaxime, moxalactam, and carbenicillin, combined with tobramycin, against Pseudomonas aeruginosa

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185575

Bactericidal and synergistic activity of moxalactam alone and in combination with gentamicin against Pseudomonas aeruginosa

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185575

Emergence of resistance to beta-lactam and aminoglycoside antibiotics during moxalactam therapy of Pseudomonas aeruginosa infections.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185575

Mechanisms of resistance to aminoglycosides

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185575

Pseudomonas bacteremia. Review of 108 cases

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185575

Significance of antimicrobial synergism for the outcome of gram negative sepsis

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185575

Gentamicin-resistant Pseudomonas aeruginosa and Serratia marcescens in a general hospital

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185575

Clinical efficacy of aminoglycosides: an example of balance between microbiology and pharmacology

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=185575

Prediction and significance of synergy between antibiotics used for treatment for gram-negative sepsis

29 May 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/6428310

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Antibiotics of choice in suspected serious sepsis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/6428310

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.25.4.534

1 reference

16 October 2017

1 reference

16 October 2017

1 reference